Home/Pipeline/Varenicline Tablets

Varenicline Tablets

Smoking Cessation

ApprovedCommercial Launch PendingANDA

Key Facts

Indication

Smoking Cessation

Phase

Approved

Status

Commercial Launch Pending

Company

Indoco Remedies

About Indoco Remedies

Founded in 1947, Indoco Remedies has evolved from a trading concern into a $15+ billion market cap pharmaceutical enterprise with a mission to deliver high-quality, affordable medicines globally. Its core strategy is built on vertical integration, combining API synthesis with sophisticated formulation development in complex generics, particularly sterile injectables, ophthalmics, and oral solutions. Recent achievements include multiple USFDA ANDA approvals, successful regulatory inspections with zero observations, and strategic expansion into key international markets like the US and Europe through partnerships and acquisitions.

View full company profile

Therapeutic Areas

CNS / Epilepsy Cardiovascular Anti-infectives Ophthalmology Metabolic Disorders

Other Smoking Cessation Drugs

Drug	Company	Phase	Status
Nicotine Oral Strip	CTT Pharma	Pre-clinical	Active
Smoking Cessation Program	Qnovia	Pre-clinical	Active
Platform Expansion	Amygdala Neurosciences	Research	Active
NFL-101	NFL Biosciences	Phase 2	Active
NFL-102	NFL Biosciences	Phase 2	Active
DehydraTECH-Nicotine	Lexaria Bioscience	Human Clinical	Active